Glaukos Corporation
Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
See below for the Latest Glaukos Corporation News, Analysis, Profit Results, Share Price Information, and Commentary.
Micro stents, macro efficiency: How a tiny device helps preserve vision
Micro stents, macro efficiency: How a tiny device helps preserve vision
Glaukos Corporation’s iStent inject W helps preserve vision by addressing high eye pressure.
Most Read
1. New Research and Innovation Centre opens at Launceston General Hospital 2. Hong Kong's pathway for doctors may boost innovation 3. Chinese Medicine Hospital named ‘teaching hub’ for 3 HK universities 4. Saudi Arabia’s Fakeeh Care to pilot AI remote patient monitoring in new partnership 5. IHH Healthcare’s net profit drops 29% to $105m in Q2Resource Center
Read Here
Advertise
Sign Up
Event News
Healthcare Asia Awards 2025 Winner: Tanupol Virunhagarun, M.D. of BDMS Wellness Clinic
Tanupol Virunhagarun, M.
